FCM
ELOS

Frontier Capital Management’s Syneron Medical Ltd ELOS Stock Holding History

Frontier Capital Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-145,511
Closed -$1.46M – 373
2014
Q3 		$1.46M Sell
145,511
-60,839
-29% -$619K 0.01% 309
2014
Q2 		$2.13M Sell
206,350
-29,470
-12% -$319K 0.02% 308
2014
Q1 		$2.94M Sell
235,820
-178,120
-43% -$2.11M 0.02% 310
2013
Q4 		$5.09M Sell
413,940
-112,130
-21% -$1.16M 0.04% 282
2013
Q3 		$4.54M Sell
526,070
-209,755
-29% -$1.81M 0.03% 291
2013
Q2 		$6.4M Buy
+735,825
New +$6.58M 0.05% 276

Other funds holding ELOS

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
HC
Hourglass Capital Houston, Texas $480M AUM 32.35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Frontier Capital Management's ELOS Position: Q4 2014 in Review

Frontier Capital Management sold out of Syneron Medical Ltd (ELOS) in Q4 2014, closing a stake of 145,511 shares — an estimated $1.46M sold.

Frontier Capital Management first reported a position in ELOS in Q2 2013 and held it in 6 quarters. The position peaked at $6.4M in Q2 2013. 68 funds tracked by Wall St. Rank hold ELOS as of Q4 2014.

  • Frontier Capital Management reported no remaining Syneron Medical Ltd position as of Q4 2014 after selling out during the quarter.
  • Frontier Capital Management sold 145,511 Syneron Medical Ltd shares in Q4 2014, an estimated $1.46M.
  • Frontier Capital Management first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 6 quarters.
  • Frontier Capital Management's Syneron Medical Ltd position peaked at $6.4M in Q2 2013.
  • 68 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q4 2014.

Based on Frontier Capital Management's 13F filing for Q4 2014, filed 23 Jan 2015.